Akebia Therapeutics, Inc. AKBA
- AKB-097 — C3 Glomerulopathy Phase 2
- AKB-097 — IgA Nephropathy Phase 2
- AKB-097 — Lupus Nephritis Phase 2
C3d (1 companies · 3 programs)
Companies with an active program directed at C3d.
Companies with an active program directed at C3d.